Skip to main content
SpringerLink
Log in

A recent report has predicted that hepatitis C virus (HCV) drug sales will almost quadruple by 2013, across major markets

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Decision Resources Inc.Hepatitis C Virus Market Will Expand Dramatically From $2 Billion in 2008 to Nearly $7.7 Billion in 2013. Media Release: 22 Jun 2009. Available from: URL: http://www.decisionresources.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

A recent report has predicted that hepatitis C virus (HCV) drug sales will almost quadruple by 2013, across major markets. Pharmacoecon. Outcomes News 581, 10 (2009). https://doi.org/10.2165/00151234-200905810-00034

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905810-00034

Keywords

Search

Navigation